US EditionAdalimumab Biosimilars Show Similar Outcomes in Psoriasis After Nonmedical Switch
Summary by centerforbiosimilars.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
All
Left
Center
Right
Agreement to improve access to psoriasis treatment
Psoriasis is one of the most frequent dermatological diseases. Family and Community Medicine specialists have a key role in its diagnosis and management. In this context, Reig Jofre and LEO Pharma have signed an agreement with the aim of strengthening the promotion of innovative treatment for cases of this mild to moderate disease in the field of primary care in Spain by LEO Pharma, a pharmaceutical laboratory specializing in medical dermatology…
·Spain
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
